£58.00

Books on Demand Stabilität hoher Fluorchinolonresistenz bei Enterobakterien ohne Selektionsdruck

Price data last checked 100 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£58 today · cheaper than every other day in the last 24 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 631 days • 631 data points (No recent data available)

Historical
Generating forecast...
£58.00 £55.10 £56.26 £57.42 £58.58 £59.74 £60.90 23 May 2024 27 October 2024 03 April 2025 07 September 2025 12 February 2026

Price Distribution

Price distribution over 631 days • 1 price levels

Days at Price
631 days 0 158 316 473 631 £58 Days at Price

Price Analysis

Most common price: £58 (631 days, 100.0%)

Price range: £58 - £58

Price levels: 1 different prices over 631 days

Description

Dissertation / Doktorarbeit, die am 31.08.2001 erfolgreich an einer Universität in Deutschland im Fachbereich Medizinische Fakultät eingereicht wurde. Beide Auszeichnungen wurden auf Vorschlag der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. verliehen. Der Aventis Travel Award 2001 war ein Stipendium zum Besuch der 40th ICAAC, Toronto, Kanada, gestiftet von Aventis Pharma GmbH. Zusammenfassung: Als Präventivmaßnahme zur Eindämmung der Resistenz gegen Antibiotika wurde 1995 von der WHO vorgeschlagen, den Antibiotikaeinsatz weltweit zu reduzieren, um damit der Selektion von resistenten Bakterien entgegenzuwirken. Grundlage dieser WHO-Empfehlung ist die Annahme, daß die Fitness von Antibiotika-resistenten Mutanten im Vergleich zu sensitiven Stämmen signifikant verringert ist und diese daher beim Wegfall des Selektionsdrucks die resistenten Stämme verdrängen. Die klinische Fluorchinolonresistenz bei Escherichia coli ist eine Folge der Akkumulation von Mutationen in den Genen der Zielstrukturen Gyrase und Topoisomerase IV. Des weiteren spielt oftmals eine Veränderung der mar-regulierten Expression von Porinen und Effluxpumpen eine Rolle. Bei in vitro selektierten E. coli konnte, im Zusammenhang mit der Resistenzentwicklung, eine erhebliche Verminderung der Fitness festgestellt werden. Neben einer verlängerten Generationszeit, wurde die Abnahme des negativen Superspiralisierungsgrads der DNA, sowie der Verlust der Typ 1 Fimbrienexpression festgestellt. Dies steht im Gegensatz zu den Befunden bei klinischen Isolaten. Um die Frage zu klären, ob der Fitnessverlust der Bakterien die WHO-Annahme bestätigt, oder, ob eventuell kompensatorische Mutationen diesen Fitnessverlust ausgleichen können, wurde in dieser Arbeit ein Fitness-Kompensationsexperiment durchgeführt. Es bestand darin, die Ciprofloxacin-resistenten Zellen über 300 Generationen ohne Antibiotikaselektionsdruck in vitro zu kultivieren, dabei setzten sich die

Product Specifications

Format
Paperback
Domain
Amazon UK
Release Date
01 January 2001
Listed Since
06 February 2009

Barcode

No barcode data available

Similar Products You Might Like

Ciprofloxacin: Biosynthesis, Applications, and Adverse Effects
95% match

Ciprofloxacin: Biosynthesis, Applications, and Adverse Effects

£105.37 28 Jan 2026
New Weapons to Control Bacterial Growth
95% match

New Weapons to Control Bacterial Growth

Springer

£179.99 13 Apr 2026
Enzybiotics: Antibiotic Enzymes as Drugs and Therapeutics
94% match

Enzybiotics: Antibiotic Enzymes as Drugs and Therapeutics

Wiley

£72.26 05 Feb 2026
Pathogenic Escherichia Coli: Molecular and Cellular Microbiology
94% match

Pathogenic Escherichia Coli: Molecular and Cellular Microbiology

Caister Academic Press Limited

£197.25 13 Jan 2026
Emerging Trends in Antibacterial Discovery: Answering the Call to Arms
94% match

Emerging Trends in Antibacterial Discovery: Answering the Call to Arms

Caister Academic Press Limited

£188.70 24 Jan 2026
Bacterial Resistance to Antimicrobials
94% match

Bacterial Resistance to Antimicrobials

CRC Press

£150.59 25 Jan 2026
Antibiotic Resistance Protocols: Second Edition: 642 (Methods in Molecular Biology, 642)
94% match

Antibiotic Resistance Protocols: Second Edition: 642 (Methods in Molecular Biology, 642)

Humana

£95.00 25 Feb 2026
Immunology and Infectious Disease: 3 (Molecular & Cellular Biology of Critical Care Medicine, 3)
94% match

Immunology and Infectious Disease: 3 (Molecular & Cellular Biology of Critical Care Medicine, 3)

Springer

£57.97 08 Mar 2026
Waste Biomass Management – A Holistic Approach
94% match

Waste Biomass Management – A Holistic Approach

Springer

£109.24 10 Jan 2026
Antimicrobial Therapies: Methods and Protocols: 2296 (Methods in Molecular Biology, 2296)
94% match

Antimicrobial Therapies: Methods and Protocols: 2296 (Methods in Molecular Biology, 2296)

£124.50 12 Jan 2026
Management of Antimicrobials in Infectious Diseases: Impact of Antibiotic Resistance
94% match

Management of Antimicrobials in Infectious Diseases: Impact of Antibiotic Resistance

Humana

£168.80 06 Feb 2026
Principles and Applications of Up-converting Phosphor Technology
94% match

Principles and Applications of Up-converting Phosphor Technology

Springer

£73.85 10 Mar 2026
Practical Atlas for Bacterial Identification
94% match

Practical Atlas for Bacterial Identification

CRC Press

£27.50 07 Mar 2026
Bacterial Resistance to Antimicrobials
94% match

Bacterial Resistance to Antimicrobials

CRC Press

£62.43 28 Jan 2026
Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, Volume 2 (Infectious Disease)
94% match

Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, Volume 2 (Infectious Disease)

Humana

£193.64 07 Jan 2026
Two-Component Systems in Bacteria
94% match

Two-Component Systems in Bacteria

Caister Academic Press Limited

£218.97 25 Jan 2026
Antibiotics: Methods and Protocols: 1520 (Methods in Molecular Biology, 1520)
94% match

Antibiotics: Methods and Protocols: 1520 (Methods in Molecular Biology, 1520)

Humana

£80.39 13 Apr 2026
Human Microbiome in Health and Disease - Part A (Volume 191) (Progress in Molecular Biology and Translational Science, Volume 191)
94% match

Human Microbiome in Health and Disease - Part A (Volume 191) (Progress in Molecular Biology and Translational Science, Volume 191)

Academic Press

£111.79 17 Apr 2026
The Influence of Antibiotics on the Host-Parasite Relationship II
94% match

The Influence of Antibiotics on the Host-Parasite Relationship II

Springer

£74.58 16 Feb 2026
21st Century Challenges in Antimicrobial Therapy and Stewardship (Frontiers in Anti-Infective Agents)
94% match

21st Century Challenges in Antimicrobial Therapy and Stewardship (Frontiers in Anti-Infective Agents)

£106.80 05 Apr 2026
E. coli: Genomics, Evolution and Pathogenesis
94% match

E. coli: Genomics, Evolution and Pathogenesis

Academic Press

£78.26 24 Feb 2026
Bacterial Pathogenesis of Plants and Animals: Molecular and Cellular Mechanisms: 192 (Current Topics in Microbiology and Immunology, 192)
94% match

Bacterial Pathogenesis of Plants and Animals: Molecular and Cellular Mechanisms: 192 (Current Topics in Microbiology and Immunology, 192)

Springer

£76.45 02 Mar 2026
Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, Volume 2
94% match

Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, Volume 2

Springer

£197.91 28 Jan 2026
Antibiotics - Therapeutic Spectrum and Limitations (Developments in Microbiology)
94% match

Antibiotics - Therapeutic Spectrum and Limitations (Developments in Microbiology)

£114.49 12 Jan 2026